In an explicit rebuke to the federal government's recent pivot on newborn vaccinations, New York health officials are steadfastly maintaining their existing hepatitis B vaccine guidelines. Despite a new recommendation from a CDC advisory panel, which suggests delaying the first dose of the vaccine until a child is two months old unless their mother tests positive for the virus, local authorities are making it unequivocally clear: there's no change coming for the Empire State's infants.
As reported by CBS News New York, Acting Health Commissioner Dr. Michelle Morse underscored New York City's commitment to the standard of newborn care. "I want to be very clear, as the city's doctor, that the standard of care in New York City and New York state remains that children who are born, babies who are born, should have a dose of the hepatitis B vaccine within 24 hours of delivery," Morse said. Her stance challenges the CDC panel's decision, which received support from President Trump and Health and Human Services Secretary Robert F. Kennedy Jr., a well-known vaccine skeptic.
Experts like Dr. Irwin Redlener of Columbia University are questioning the logic behind the advisory panel's vote. In a commentary to CBS News, Redlener labeled the panel's move as unfounded and potentially damaging, stating, "There's really no scientific reason whatsoever to stop doing a procedure that was actually saving millions of lives and millions of children." The strong opposition from New York State reflects a broader adherence to established health policies despite shifting federal narratives. Morse's sentiments, as expressed in an interview with CBS News New York, emphasize the city's dismay towards federal agencies deviating from their foundational mission to follow science-backed public health practices.
Amid the disagreement between local and federal guidance, the significance of this vaccine cannot be overstressed. "Half of the people who have hepatitis B actually don't know they have it," Morse told Gothamist.
The same sentiment was echoed by Dr. James McDonald, the New York State Health Commissioner, who highlighted the state's success in preventing hepatitis B transmissions among newborns: "We haven't had a case of hepatitis B in New York state since 2017 because we've had a very successful policy." Both state and city health leaders, as Morse noted, will continue to advocate for the adherence to longstanding guidelines around the hepatitis B vaccine and other immunizations, including school vaccine requirements, as per the CBS News New York.
In this climate of uncertainty and mixed messages, New York's robust stance brings a measure of clarity to concerned parents and healthcare providers. While the CDC director has yet to approve the panel's recommendations, New York City's health department, recognizable by its ongoing efforts in local outreach and policy, remains a pillar for consistent, science-based guidance. The city's health department's resources, as mentioned by Morse, are being positioned as the reliable go-to for New Yorkers seeking accurate vaccine information in the wake of federal committee's contentious vote.
